Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
about
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long-Term Safety and Effective ...... nalysis of the ESPRIT Registry
@en
type
label
Long-Term Safety and Effective ...... nalysis of the ESPRIT Registry
@en
prefLabel
Long-Term Safety and Effective ...... nalysis of the ESPRIT Registry
@en
P2093
P2860
P1476
Long-Term Safety and Effective ...... nalysis of the ESPRIT Registry
@en
P2093
Anne Camez
Arijit Ganguli
Diamant Thaçi
Dianlin Guo
Dilek Arikan
Francisco Kerdel
Mareike Bereswill
Wendell C Valdecantos
William Abramovits
P2860
P2888
P304
P356
10.1007/S13555-017-0198-X
P577
2017-08-16T00:00:00Z
P6179
1091222490